To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene MTRRTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
334 supporting clones for gene MTRR back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AF121214   .a 1 to 3270 1 to 3276 I49M S202L tiling clone, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 3276/3276
(100 %)
9 diff
(99.8 %id)
BC109216 PCR rescued clones .a 1 to 2429 1 to 2429 S202L tiling clone,   2429/2429
(100 %)
2 diff
(100.0 %id)
NM_024010.2   .a 1 to 3270 1 to 3270 exact RefSeq, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 3270/3270
(100 %)
0 diff
(100 %id)
DA387730 thalamus .a 10 to 582 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DB096267 testis .a 28 to 563 2 to 538   capped   537/537
(100 %)
2 diff
(99.7 %id)
AK308442 uterus .a 45 to 1326 1 to 1282       1282/1282
(100 %)
3 diff
(99.8 %id)
DB260805 uterus .a 45 to 596 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
DA123220 cerebellum .a 46 to 207 2 to 163   capped   162/162
(100 %)
1 diff
(99.4 %id)
DB277516 uterus .a 46 to 576 2 to 533   capped   532/532
(100 %)
1 diff
(99.9 %id)
DA433359 tongue, tumor tissue .a 57 to 840 2 to 796   capped   795/795
(100 %)
17 diff
(97.9 %id)
DA888024   .a 59 to 585 2 to 529   capped   528/528
(100 %)
1 diff
(99.9 %id)
DA992251 synovial membrane tissue from rheumatioidarthritis .a 59 to 617 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA437138 tongue, tumor tissue .a 61 to 637 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DA452457 tongue, tumor tissue .a 61 to 622 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA709306   .a 61 to 626 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
DA854981 placenta .a 61 to 652 2 to 593   capped   592/592
(100 %)
0 diff
(100 %id)
CX756992 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 110 to 856 1 to 740     Submitted on the opposite strand 740/817
(90 %)
25 diff
(97.0 %id)
BU570323 testis .a 277 to 783 1 to 511       511/710
(71 %)
16 diff
(97.8 %id)
AW407783 lymph .a 301 to 482 1 to 183       182/183
(99 %)
16 diff
(91.3 %id)
AA192690 muscle, skeletal muscle .a 379 to 594 216 to 1       216/234
(92 %)
0 diff
(100 %id)
DN917645   .a 444 to 992 583 to 37       547/587
(93 %)
11 diff
(98.2 %id)
BF852409 lung_normal .a 487 to 677 199 to 12     Submitted on the opposite strand 188/199
(94 %)
0 diff
(100 %id)
BU941078 mixed (pool of 40 RNAs) .a 488 to 1207 1 to 714       716/823
(86 %)
19 diff
(97.7 %id)
BF850765 lung_normal .a 520 to 805 37 to 324       288/324
(88 %)
6 diff
(98.2 %id)
CD559384 pooled .a 534 to 1179 1 to 649       649/818
(79 %)
16 diff
(98.1 %id)
BF852408 lung_normal .a 545 to 1005 42 to 503       462/503
(91 %)
10 diff
(98.1 %id)
DB125706 thymus .a 569 to 1061 2 to 494   capped   493/493
(100 %)
1 diff
(99.8 %id)
BI025277 marrow .a 586 to 1070 41 to 527       487/527
(92 %)
6 diff
(98.9 %id)
BI025283 marrow .a 586 to 1120 48 to 586       539/591
(91 %)
7 diff
(98.9 %id)
DB184208 liver, tumor tissue .a 615 to 1190 2 to 577   tiling clone, capped   576/576
(100 %)
0 diff
(100 %id)
BF810368 colon_ins .a 625 to 1014 19 to 408       390/413
(94 %)
7 diff
(98.4 %id)
BF810479 colon_ins .a 625 to 1014 19 to 408       390/413
(94 %)
7 diff
(98.4 %id)
BX348674 Neuroblastoma Cot 25-normalized .a 759 to 1656 1 to 892       892/908
(98 %)
26 diff
(97.2 %id)
DA597427   .a 860 to 1418 2 to 560   capped   559/560
(99 %)
3 diff
(99.5 %id)
AU279788   .a 930 to 1494 1 to 565       565/565
(100 %)
0 diff
(100 %id)
DA820057   .a 959 to 1542 2 to 585   capped   584/584
(100 %)
2 diff
(99.7 %id)
BF692961 muscle (skeletal) .a 967 to 1597 1 to 627       627/631
(99 %)
18 diff
(97.2 %id)
DA152947 amygdala .a 973 to 1508 2 to 537   capped   536/536
(100 %)
0 diff
(100 %id)
DA476011   .a 983 to 1557 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA478205   .a 990 to 1567 2 to 580   capped   579/579
(100 %)
2 diff
(99.7 %id)
BF808461 colon_ins .a 1041 to 1402 1 to 362       362/366
(98 %)
4 diff
(99.0 %id)
CN260357 embryonic stem cells, cell lines H1, H7, andH9 .a 1085 to 1720 12 to 646       635/646
(98 %)
6 diff
(99.1 %id)
AA342222 Spleen .a 1098 to 1364 1 to 267       267/271
(98 %)
1 diff
(99.7 %id)
BQ218755 embryonal carcinoma, cell line, testis .a 1106 to 1671 1 to 569       569/1061
(53 %)
6 diff
(99.5 %id)
BI007651 kidney_tumor .a 1222 to 1787 59 to 624       566/626
(90 %)
48 diff
(92.4 %id)
BE539174 cervix .a 1252 to 1941 1 to 694       691/758
(91 %)
41 diff
(94.6 %id)
AA355001   .a 1302 to 1668 1 to 368       368/368
(100 %)
3 diff
(99.2 %id)
AW965709   .a 1303 to 1877 1 to 567       567/591
(95 %)
16 diff
(97.3 %id)
AL704780 human skeletal muscle .a 1337 to 1623 14 to 300       287/301
(95 %)
7 diff
(97.7 %id)
BG390491 embryonal carcinoma, cell line, testis .a 1338 to 2116 1 to 765       765/945
(80 %)
27 diff
(97.2 %id)
BG531787 embryonal carcinoma, testis .a 1349 to 2051 1 to 696       695/839
(82 %)
26 diff
(97.0 %id)
AV659098 corresponding non cancerous liver tissue .a 1353 to 1775 1 to 423     Submitted on the opposite strand 423/423
(100 %)
7 diff
(98.4 %id)
DA404418 thalamus .a 1359 to 1958 2 to 601   capped   600/600
(100 %)
0 diff
(100 %id)
AU310610 neuroblastoma .a 1474 to 2056 1 to 583     Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 583/583
(100 %)
0 diff
(100 %id)
DB461694 testis .a 1551 to 1954 1 to 404       404/404
(100 %)
12 diff
(97.1 %id)
BQ431497 melanotic melanoma, skin .a 1572 to 2387 1 to 825       825/852
(96 %)
12 diff
(98.6 %id)
AI536117 Prostate .a 1617 to 2133 29 to 542     Submitted on the opposite strand 514/593
(86 %)
16 diff
(97.4 %id)
CB164340 Liver .a 1651 to 2171 1 to 521       521/521
(100 %)
2 diff
(99.7 %id)
BM837288 Ascites, stomach .a 1663 to 2113 1 to 451       451/451
(100 %)
18 diff
(96.1 %id)
BF346446 anaplastic oligodendroglioma with 1p/19qloss, brain .a 1692 to 2330 1 to 642       642/642
(100 %)
6 diff
(99.1 %id)
DB518561 testis .a 1693 to 2372 1 to 679     Submitted on the opposite strand 679/680
(99 %)
4 diff
(99.5 %id)
CK002453 brain/CNS, Bulk tissue from Human Spinal cord .a 1699 to 2307 1 to 594       594/620
(95 %)
24 diff
(96.2 %id)
N56697 placenta .a 1746 to 2013 1 to 267       267/272
(98 %)
4 diff
(98.6 %id)
N56727 placenta .a 1746 to 2032 1 to 286       286/296
(96 %)
4 diff
(98.7 %id)
BF692712 melanotic melanoma, high MDR, skin .a 1831 to 2491 1 to 647   AAA   647/858
(75 %)
17 diff
(98.1 %id)
R17835 whole brain .a 1845 to 2127 1 to 283       283/288
(98 %)
2 diff
(99.4 %id)
AA085543   .a 1846 to 2211 1 to 366       366/366
(100 %)
1 diff
(99.8 %id)
BF242882 bone marrow, from acute myelogenous leukemia .a 1855 to 2555 1 to 693       693/909
(76 %)
30 diff
(96.7 %id)
BF575963 muscle (skeletal) .a 1855 to 2490 1 to 631       631/870
(72 %)
19 diff
(97.9 %id)
BF691209 melanotic melanoma, high MDR, skin .a 1900 to 2613 1 to 706       706/899
(78 %)
18 diff
(98.0 %id)
EH348530   .a 1906 to 1989 1 to 84       84/85
(98 %)
5 diff
(94.2 %id)
BG877205 head_neck .a 1907 to 2343 440 to 5       436/440
(99 %)
1 diff
(99.8 %id)
FN170242 breast carcinoma .a 1909 to 2009 102 to 1     Submitted on the opposite strand 102/102
(100 %)
2 diff
(98.1 %id)
AA469901   .a 1909 to 2218 15 to 324       310/324
(95 %)
6 diff
(98.2 %id)
CN260358 embryonic stem cells, cell lines H1, H7, andH9 .a 1948 to 2588 1 to 641       641/641
(100 %)
1 diff
(99.9 %id)
FN110623 breast carcinoma .a 1957 to 2048 1 to 89       89/93
(95 %)
6 diff
(93.6 %id)
FN129351 breast carcinoma .a 1962 to 2055 90 to 1     Submitted on the opposite strand 90/91
(98 %)
3 diff
(96.8 %id)
W23792 senescent fibroblast .a 1966 to 2202 1 to 237       237/237
(100 %)
1 diff
(99.6 %id)
BF667260 brain, primitive neuroectoderm .a 1987 to 2722 1 to 733       733/738
(99 %)
20 diff
(97.3 %id)
BF215281 bone marrow, from acute myelogenous leukemia .a 1988 to 2622 1 to 654       654/714
(91 %)
35 diff
(95.1 %id)
DN916929   .a 2014 to 2659 1 to 641       641/641
(100 %)
11 diff
(98.3 %id)
N44258 melanocyte .a 2019 to 2479 1 to 464     Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 464/464
(100 %)
4 diff
(99.2 %id)
AA242870 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2019 to 2511 1 to 493       493/493
(100 %)
1 diff
(99.8 %id)
BF246729 brain, glioblastoma .a 2025 to 2724 1 to 700       700/877
(79 %)
43 diff
(95.1 %id)
BX093000 liver and spleen .a 2090 to 2911 1 to 824       824/824
(100 %)
4 diff
(99.6 %id)
T97979 liver and spleen .a 2099 to 2370 1 to 284       284/286
(99 %)
18 diff
(93.8 %id)
H70102 liver and spleen .a 2122 to 2592 1 to 483       483/483
(100 %)
16 diff
(96.7 %id)
BM785852 Ascites, stomach .a 2171 to 2862 1 to 691       691/691
(100 %)
1 diff
(99.9 %id)
BM887906 eye .a 2212 to 2774 1 to 563       563/563
(100 %)
2 diff
(99.7 %id)
DN916928   .a 2219 to 2829 611 to 1       611/612
(99 %)
1 diff
(99.9 %id)
AA322063 brain, cerebellum .a 2226 to 2486 1 to 261       261/261
(100 %)
1 diff
(99.7 %id)
N29717 placenta .a 2277 to 2768 496 to 1       496/508
(97 %)
12 diff
(97.7 %id)
BF102779 adenocarcinoma, Prostate .a 2293 to 3007 1 to 694       694/826
(84 %)
26 diff
(96.9 %id)
AA905139 pooled .a 2306 to 2767 464 to 3       462/464
(99 %)
0 diff
(100 %id)
FN089753 breast carcinoma .a 2309 to 2400 1 to 91       91/103
(88 %)
8 diff
(92.3 %id)
AW135499   .a 2310 to 2766 474 to 18   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 457/457
(100 %)
1 diff
(99.8 %id)
CD638642 pooled .a 2330 to 2767 1 to 438   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 438/439
(99 %)
3 diff
(99.4 %id)
BE544587 cervical carcinoma cell line, cervix .a 2341 to 3122 1 to 784       784/790
(99 %)
19 diff
(97.6 %id)
BE548919 cervical carcinoma cell line, cervix .a 2342 to 3100 1 to 754       754/754
(100 %)
30 diff
(96.1 %id)
AA416936   .a 2353 to 2770 418 to 1       418/418
(100 %)
2 diff
(99.6 %id)
N29688.
matches multiple genes
placenta .a 2358 to 2768 414 to 1     also hits gene IER3IP1andHDHD2 414/427
(96 %)
10 diff
(97.7 %id)
BF700759 brain, primitive neuroectoderm .a 2359 to 2976 1 to 617       617/889
(69 %)
54 diff
(94.0 %id)
BM762822 lymph node, stomach .a 2359 to 2868 1 to 510       510/510
(100 %)
2 diff
(99.7 %id)
BU161922 leiomyosarcoma, uterus .a 2390 to 3183 1 to 803       803/898
(89 %)
17 diff
(98.2 %id)
AA905280 pooled .a 2407 to 2767 363 to 3       361/363
(99 %)
0 diff
(100 %id)
BM468590 leiomyosarcoma, uterus .a 2412 to 3270 1 to 859   tiling clone, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 859/859
(100 %)
2 diff
(99.8 %id)
AI061048   .a 2421 to 2768 359 to 12   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 348/348
(100 %)
2 diff
(99.5 %id)
AI220668 placenta .a 2426 to 2770 349 to 5       345/349
(98 %)
0 diff
(100 %id)
TI_149285956   .a 2450 to 3261 897 to 88   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 810/812
(99 %)
23 diff
(97.2 %id)
TI_149311389   .a 2454 to 3270 912 to 103   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 810/947
(85 %)
18 diff
(98.1 %id)
D61122   .a 2481 to 2754 1 to 276       276/276
(100 %)
2 diff
(99.3 %id)
D81434 brain .a 2481 to 2696 1 to 216       216/216
(100 %)
0 diff
(100 %id)
FN102623 breast carcinoma .a 2506 to 2608 1 to 105       105/105
(100 %)
1 diff
(99.1 %id)
BX351007 Neuroblastoma Cot 25-normalized .a 2529 to 3277 754 to 1       754/927
(81 %)
50 diff
(94.7 %id)
AL046883 uterus .a 2534 to 3128 1 to 596       596/607
(98 %)
2 diff
(99.7 %id)
DB559453 hypothalamus .a 2541 to 3262 1 to 721     Submitted on the opposite strand 721/721
(100 %)
7 diff
(99.1 %id)
BU689429 lung .a 2548 to 3270 740 to 19   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 722/723
(99 %)
5 diff
(99.4 %id)
TI_149288765   .a 2552 to 3261 788 to 80   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 709/710
(99 %)
5 diff
(99.3 %id)
R34816 placenta .a 2553 to 2894 1 to 350     Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 350/366
(95 %)
15 diff
(96.0 %id)
H02679 placenta .a 2553 to 2882 1 to 334       334/334
(100 %)
5 diff
(98.6 %id)
AW753025 colon .a 2591 to 3133 555 to 9       547/555
(98 %)
0 diff
(100 %id)
BM970578 lung .a 2604 to 3261 675 to 19   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 657/657
(100 %)
2 diff
(99.7 %id)
BE467623 carcinoid, lung .a 2668 to 3269 601 to 1       601/601
(100 %)
2 diff
(99.7 %id)
AA451664   .a 2701 to 3128 1 to 427       427/427
(100 %)
2 diff
(99.6 %id)
BF692057 melanotic melanoma, high MDR, skin .a 2731 to 3262 1 to 531   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 531/532
(99 %)
6 diff
(98.9 %id)
BM971794 lung .a 2733 to 3261 547 to 19   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 529/529
(100 %)
1 diff
(99.9 %id)
BP389400 pancreatic islet .a 2752 to 3249 1 to 500     Submitted on the opposite strand 500/500
(100 %)
2 diff
(99.6 %id)
DB545442 hippocampus .a 2756 to 3262 1 to 506     Submitted on the opposite strand 506/506
(100 %)
3 diff
(99.5 %id)
AI680201 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 2756 to 3271 515 to 1       515/515
(100 %)
4 diff
(99.3 %id)
T26679.
matches multiple genes
  .a 2759 to 3261 503 to 1     also hits gene LRRC8CandLRRC8D 503/510
(98 %)
4 diff
(99.3 %id)
AU310611 neuroblastoma .a 2759 to 3262 544 to 42   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 503/503
(100 %)
2 diff
(99.7 %id)
DB545566 hippocampus .a 2768 to 3260 1 to 492     Submitted on the opposite strand 492/492
(100 %)
2 diff
(99.6 %id)
DB542939 hippocampus .a 2773 to 3260 1 to 488     Submitted on the opposite strand 488/490
(99 %)
5 diff
(99.0 %id)
AW168011 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 2776 to 3255 479 to 1       479/479
(100 %)
2 diff
(99.6 %id)
AI027905 parathyroid gland, parathyroid tumor .a 2777 to 3258 485 to 5       481/485
(99 %)
0 diff
(100 %id)
BE467494 carcinoid, lung .a 2777 to 3269 492 to 1       492/492
(100 %)
2 diff
(99.6 %id)
BE671014 carcinoid, lung .a 2777 to 3266 491 to 3       489/491
(99 %)
0 diff
(100 %id)
AI033997 parathyroid gland, parathyroid tumor .a 2778 to 3266 490 to 3       488/490
(99 %)
0 diff
(100 %id)
AI276625 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2778 to 3262 485 to 1       485/485
(100 %)
0 diff
(100 %id)
BF476484 Prostate .a 2780 to 3274 494 to 1       494/494
(100 %)
6 diff
(98.8 %id)
AI091577 pooled .a 2783 to 3255 489 to 17   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 473/473
(100 %)
6 diff
(98.8 %id)
BE222505 carcinoid, lung .a 2784 to 3271 488 to 1       488/488
(100 %)
1 diff
(99.8 %id)
DB524229 testis .a 2789 to 3270 1 to 481     Submitted on the opposite strand 481/481
(100 %)
3 diff
(99.4 %id)
DB543502 hippocampus .a 2792 to 3262 1 to 470     Submitted on the opposite strand 470/470
(100 %)
2 diff
(99.6 %id)
AI654983 pooled germ cell tumors .a 2792 to 3274 483 to 4       480/492
(97 %)
0 diff
(100 %id)
DB549629 hippocampus .a 2810 to 3260 1 to 450     Submitted on the opposite strand 450/452
(99 %)
4 diff
(99.2 %id)
DB557029 hypothalamus .a 2811 to 3262 1 to 451     Submitted on the opposite strand 451/451
(100 %)
5 diff
(98.9 %id)
N23998 melanocyte .a 2816 to 3271 458 to 1       458/459
(99 %)
5 diff
(99.0 %id)
AA484628 Kidney .a 2816 to 3227 1 to 411       411/411
(100 %)
7 diff
(98.3 %id)
DB535886 hippocampus .a 2817 to 3260 1 to 445     Submitted on the opposite strand 445/447
(99 %)
7 diff
(98.5 %id)
DB538725 hippocampus .a 2824 to 3260 1 to 437     Submitted on the opposite strand 437/437
(100 %)
5 diff
(98.9 %id)
BE467646 carcinoid, lung .a 2826 to 3273 447 to 1       447/447
(100 %)
6 diff
(98.7 %id)
AI580777 uterus .a 2830 to 3266 438 to 3       436/438
(99 %)
0 diff
(100 %id)
AI080198 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2835 to 3258 427 to 5       423/427
(99 %)
0 diff
(100 %id)
AI142966 senescent fibroblast .a 2835 to 3274 442 to 3       440/442
(99 %)
0 diff
(100 %id)
DB509895 testis .a 2842 to 3270 1 to 428     Submitted on the opposite strand 428/428
(100 %)
3 diff
(99.3 %id)
N36383 melanocyte .a 2843 to 3270 445 to 17   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 429/434
(98 %)
2 diff
(99.6 %id)
BF062337 pooled germ cell tumors .a 2857 to 3274 420 to 4       417/420
(99 %)
0 diff
(100 %id)
AA782062 parathyroid gland, parathyroid tumor .a 2866 to 3270 415 to 12   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 404/404
(100 %)
5 diff
(98.8 %id)
AI373715 uterus .a 2867 to 3273 407 to 1       407/407
(100 %)
0 diff
(100 %id)
AW264871 lung, two pooled squamous cell carcinomas .a 2871 to 3278 407 to 1       407/415
(98 %)
1 diff
(99.8 %id)
DB516012 testis .a 2881 to 3262 1 to 384     Submitted on the opposite strand 384/384
(100 %)
6 diff
(98.5 %id)
AA252150 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2901 to 3270 370 to 1       370/370
(100 %)
1 diff
(99.8 %id)
N94585 senescent fibroblast .a 2919 to 3270 354 to 1       354/354
(100 %)
3 diff
(99.2 %id)
AI758177 Kidney .a 2941 to 3270 328 to 1       328/328
(100 %)
2 diff
(99.4 %id)
FN168569 breast carcinoma .a 2952 to 3059 1 to 106       106/106
(100 %)
4 diff
(96.3 %id)
AI950700 lung, two pooled squamous cell carcinomas .a 2963 to 3261 298 to 1       298/298
(100 %)
1 diff
(99.7 %id)
BF990105 placenta_normal .a 2977 to 3162 204 to 23       182/218
(83 %)
0 diff
(100 %id)
AI872682 adenocarcinoma, Pancreas .a 2979 to 3262 287 to 1       287/287
(100 %)
3 diff
(99.0 %id)
AA781328 parathyroid gland, parathyroid tumor .a 2998 to 3244 246 to 1       246/246
(100 %)
4 diff
(98.4 %id)
AI984621 Kidney .a 2999 to 3262 281 to 18   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 264/264
(100 %)
4 diff
(98.5 %id)
AI984388 Kidney .a 3001 to 3262 279 to 18   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 262/262
(100 %)
3 diff
(98.9 %id)
T97980 liver and spleen .a 3005 to 3250 256 to 1       256/290
(88 %)
12 diff
(95.9 %id)
T32386 Spleen .a 3005 to 3270 265 to 1       265/265
(100 %)
1 diff
(99.7 %id)
AI089223 uterus .a 3035 to 3261 229 to 3       227/232
(97 %)
0 diff
(100 %id)
AI579968 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 3055 to 3270 259 to 44   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 216/216
(100 %)
1 diff
(99.6 %id)
R34706 placenta .a 3094 to 3262 186 to 16   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 171/178
(96 %)
2 diff
(98.9 %id)
AI956018 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 3161 to 3274 117 to 4       114/117
(97 %)
0 diff
(100 %id)
NM_002454.2   .b 1 to 3296 1 to 3296 exact RefSeq, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 3296/3296
(100 %)
0 diff
(100 %id)
DA409452 thalamus .b 43 to 610 2 to 570   tiling clone, capped   569/569
(100 %)
1 diff
(99.9 %id)
DB234406 trachea .b 45 to 603 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DA273830 corpus callosum .b 46 to 588 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DA770250 brain .b 46 to 608 2 to 564   capped   563/563
(100 %)
2 diff
(99.7 %id)
DA783635 brain .b 51 to 632 2 to 584   capped   583/583
(100 %)
1 diff
(99.9 %id)
DA294997 hippocampus .b 58 to 588 2 to 533   capped   532/532
(100 %)
3 diff
(99.5 %id)
AF025794   .b 59 to 3296 1 to 3244 I22M S175L tiling clone, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 3244/3244
(100 %)
9 diff
(99.8 %id)
DB195621 trachea .b 59 to 558 2 to 502   capped   501/501
(100 %)
2 diff
(99.7 %id)
DB204241 trachea .b 59 to 622 2 to 566   capped   565/565
(100 %)
3 diff
(99.5 %id)
DB468555 hippocampus .b 60 to 486 1 to 428       428/428
(100 %)
4 diff
(99.1 %id)
DB474135 hippocampus .b 60 to 564 1 to 505       505/505
(100 %)
3 diff
(99.5 %id)
DB480829 hippocampus .b 60 to 560 1 to 501       501/501
(100 %)
4 diff
(99.3 %id)
DB487642 hypothalamus .b 60 to 504 1 to 445       445/445
(100 %)
3 diff
(99.4 %id)
DA581872 lung .b 61 to 625 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
DA726240   .b 61 to 633 2 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
BX375211 Neuroblastoma Cot 25-normalized .b 67 to 1034 1 to 968       968/974
(99 %)
15 diff
(98.5 %id)
DN991485 brain, whole brain .b 69 to 798 8 to 737       730/737
(99 %)
6 diff
(99.2 %id)
BM049352 carcinoma, cell line, Prostate .b 70 to 752 1 to 685       685/685
(100 %)
8 diff
(98.9 %id)
DA407486 thalamus .b 71 to 627 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
AL121281 melanoma (MeWo cell line) .b 73 to 455 1 to 383       383/383
(100 %)
2 diff
(99.5 %id)
DB474673 hippocampus .b 78 to 585 1 to 508       508/508
(100 %)
2 diff
(99.7 %id)
DB476724 hippocampus .b 78 to 391 1 to 317       317/320
(99 %)
6 diff
(98.2 %id)
CB997527 placenta, pre-eclamptic placenta .b 78 to 819 28 to 773       746/776
(96 %)
17 diff
(97.9 %id)
CB996520 placenta, pre-eclamptic placenta .b 78 to 448 28 to 397       370/416
(88 %)
9 diff
(97.9 %id)
DA121725 cerebellum .b 79 to 644 2 to 568   capped   567/567
(100 %)
3 diff
(99.5 %id)
DA156992 amygdala .b 79 to 586 2 to 512   capped   511/511
(100 %)
5 diff
(99.1 %id)
DA869114 Prostate .b 79 to 607 2 to 531   capped   530/530
(100 %)
1 diff
(99.9 %id)
DA299190 hippocampus .b 82 to 644 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
BM838530 Ascites, stomach .b 85 to 478 1 to 395       395/395
(100 %)
2 diff
(99.5 %id)
BC054816 Lung, Spleen, fetal, pooled .b 86 to 3296 1 to 3211 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 3211/3211
(100 %)
0 diff
(100 %id)
DA190273 amygdala .b 86 to 680 2 to 596   capped   595/595
(100 %)
1 diff
(99.9 %id)
BI772430 pooled lung and spleen .b 86 to 910 1 to 825       825/826
(99 %)
4 diff
(99.6 %id)
TI_57180003   .b 86 to 910 33 to 857       825/858
(96 %)
10 diff
(98.9 %id)
DB164379 thymus .b 86 to 662 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
DA396917 thalamus .b 88 to 670 2 to 584   capped   583/583
(100 %)
2 diff
(99.7 %id)
DA400585 thalamus .b 88 to 622 2 to 536   capped   535/535
(100 %)
0 diff
(100 %id)
DA662088   .b 88 to 486 2 to 407   capped   406/413
(98 %)
7 diff
(98.4 %id)
BM801462 duodenal adenocarcinoma, cell line, small intestine .b 89 to 926 1 to 842       842/874
(96 %)
11 diff
(98.8 %id)
DA020244   .b 90 to 656 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DB470546 hippocampus .b 91 to 543 1 to 454       454/459
(98 %)
13 diff
(97.2 %id)
DB476863 hippocampus .b 91 to 591 1 to 501       501/501
(100 %)
3 diff
(99.5 %id)
DB636588 hypothalamus .b 91 to 478 1 to 388       388/388
(100 %)
2 diff
(99.5 %id)
BJ995878 hepatoblastoma .b 91 to 690 1 to 600       600/600
(100 %)
1 diff
(99.9 %id)
DA044040 bladder .b 92 to 652 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
DA159927 amygdala .b 92 to 663 2 to 573   capped   572/574
(99 %)
4 diff
(99.4 %id)
DA183475 amygdala .b 92 to 434 2 to 345   capped   344/344
(100 %)
1 diff
(99.8 %id)
DA192793 amygdala .b 92 to 605 2 to 516   capped   515/515
(100 %)
3 diff
(99.5 %id)
DA193606 amygdala .b 92 to 662 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
DA235031 brain .b 92 to 657 2 to 567   capped   566/566
(100 %)
3 diff
(99.5 %id)
DA344120 substantia nigra .b 92 to 663 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA401208 thalamus .b 92 to 393 2 to 303   capped   302/302
(100 %)
1 diff
(99.7 %id)
DA475979   .b 92 to 645 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA776603 brain .b 92 to 660 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA988385 synovial membrane tissue from rheumatioidarthritis .b 92 to 588 2 to 498   capped   497/497
(100 %)
0 diff
(100 %id)
DB099013 testis .b 92 to 674 2 to 584   capped   583/583
(100 %)
1 diff
(99.9 %id)
DB142413 thymus .b 92 to 600 2 to 510   capped   509/509
(100 %)
2 diff
(99.7 %id)
DA111413 cerebellum .b 93 to 656 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
BJ995879 hepatoblastoma .b 2753 to 3241 488 to 1       488/488
(100 %)
2 diff
(99.6 %id)
AA279726 germinal center B cell .c 1 to 386 1 to 386   tiling clone,   386/386
(100 %)
0 diff
(100 %id)
AA279695 germinal center B cell .c 1762 to 2139 377 to 1   tiling clone,   377/377
(100 %)
1 diff
(99.8 %id)
BC035977 Kidney .d 1 to 3111 1 to 3111 exact tiling clone, available from MGC, AAA   3111/3113
(99 %)
1 diff
(100.0 %id)
AU124440   .d 915 to 1787 2 to 877   capped   876/876
(100 %)
8 diff
(99.1 %id)
AU148299   .d 2572 to 3121 548 to 1   tiling clone,   548/551
(99 %)
10 diff
(98.2 %id)
DB527117 testis .d 3068 to 3522 1 to 455   tiling clone, Submitted on the opposite strand 455/457
(99 %)
2 diff
(99.6 %id)
BM754488 stomach .e 1 to 478 1 to 478   tiling clone,   478/478
(100 %)
1 diff
(99.8 %id)
CD704108 normal nasopharynx .e 39 to 522 16 to 499   tiling clone,   484/499
(96 %)
7 diff
(98.6 %id)
DA544547   .f 1 to 555 2 to 556 Y15C tiling clone, capped   555/555
(100 %)
1 diff
(99.9 %id)
BP417500 small intestine .g 1 to 471 23 to 496 P13R R14X P15X Y16I S17F ... tiling clone, Submitted on the opposite strand 474/496
(95 %)
11 diff
(97.8 %id)
DA155321 amygdala .h 1 to 566 2 to 567 exact tiling clone, capped   566/566
(100 %)
0 diff
(100 %id)
DA371164 thalamus .i-u 1 to 565 3 to 567 exact tiling clone, capped   566/566
(100 %)
0 diff
(100 %id)
DA312222 hippocampus .i-u 4 to 548 2 to 545 R42G S44R P45R R46G A47R ... capped   544/544
(100 %)
1 diff
(99.9 %id)
AL120140 amygdala .j 1 to 410 1 to 410   tiling clone,   410/410
(100 %)
0 diff
(100 %id)
DA253747 caudate nucleus .j 405 to 987 2 to 584 L115P tiling clone, capped   583/584
(99 %)
2 diff
(99.7 %id)
AW952883   .k 1 to 520 1 to 521 C124W tiling clone,   521/526
(99 %)
7 diff
(98.7 %id)
AI016080   .k 426 to 873 449 to 2   tiling clone,   448/449
(99 %)
0 diff
(100 %id)
DA792034 brain .l 1 to 519 2 to 520 E100K tiling clone, capped   519/519
(100 %)
1 diff
(99.9 %id)
BF111736 pooled .m 1 to 585 1 to 585   tiling clone, Submitted on the opposite strand 585/585
(100 %)
6 diff
(99.0 %id)
AW170391 cervix, tumor .m 371 to 865 1 to 496   tiling clone, Submitted on the opposite strand 496/496
(100 %)
3 diff
(99.4 %id)
DA243396 brain .m 795 to 1388 2 to 595   tiling clone, capped   594/594
(100 %)
0 diff
(100 %id)
BY799836 eye .n 1 to 346 1 to 346 exact tiling clone,   346/346
(100 %)
1 diff
(99.8 %id)
DB236308 trachea .o 1 to 555 2 to 555 exact tiling clone, capped   554/554
(100 %)
1 diff
(99.9 %id)
DB450934 testis .p 1 to 484 1 to 484   tiling clone,   484/484
(100 %)
6 diff
(98.8 %id)
AU098964   .p 1 to 300 1 to 300       300/300
(100 %)
6 diff
(98.0 %id)
BP873150 embryonal kidney .p 1 to 583 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
DB212865 trachea .p 2 to 546 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
CN260359 embryonic stem cells, cell lines H1, H7, andH9 .p 10 to 701 1 to 692       692/692
(100 %)
3 diff
(99.6 %id)
DB134985 thymus .p 15 to 463 2 to 450   capped   449/449
(100 %)
0 diff
(100 %id)
DA111100 cerebellum .p 17 to 605 2 to 590   capped   589/589
(100 %)
5 diff
(99.2 %id)
DB213757 trachea .p 17 to 540 2 to 527   capped   526/526
(100 %)
4 diff
(99.3 %id)
AL600207   .p 25 to 433 1 to 409       409/409
(100 %)
1 diff
(99.8 %id)
DB444923 testis .p 27 to 458 1 to 433       433/433
(100 %)
7 diff
(98.4 %id)
DB450561 testis .p 34 to 469 1 to 436       436/436
(100 %)
1 diff
(99.8 %id)
DA408054 thalamus .p 35 to 573 2 to 540   capped   539/539
(100 %)
1 diff
(99.9 %id)
DA473986   .p 35 to 606 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DB458730 testis .p 37 to 477 1 to 441       441/441
(100 %)
1 diff
(99.8 %id)
DA470612   .p 38 to 585 2 to 549   capped   548/549
(99 %)
2 diff
(99.7 %id)
DA851862 placenta .p 38 to 589 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
DB075719 testis .p 38 to 580 2 to 544   capped   543/543
(100 %)
2 diff
(99.7 %id)
DW436975 Liver .p 42 to 254 17 to 229   AAA   213/229
(93 %)
7 diff
(97.0 %id)
DW443191 Liver .p 42 to 256 17 to 231       215/231
(93 %)
11 diff
(95.3 %id)
DW445662 Liver .p 42 to 244 17 to 220       204/220
(92 %)
9 diff
(96.0 %id)
DA923862 small intestine .p 44 to 603 2 to 561   capped   560/560
(100 %)
2 diff
(99.7 %id)
CF994876 Human Placenta, placenta .p 47 to 727 28 to 708       686/892
(76 %)
20 diff
(97.8 %id)
DA448873 tongue, tumor tissue .p 48 to 607 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
DA664557   .p 48 to 819 2 to 774   capped   773/773
(100 %)
5 diff
(99.4 %id)
BC062577 Colon, Kidney, Stomach, adult, whole pooled .p 51 to 3098 1 to 3047   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 3047/3047
(100 %)
1 diff
(100.0 %id)
BI762399 pooled colon, kidney, stomach .p 51 to 712 1 to 670   available from MGC,   670/874
(76 %)
18 diff
(98.0 %id)
TI_57151234   .p 51 to 712 32 to 701       670/905
(74 %)
24 diff
(97.4 %id)
DB322091   .p 2699 to 3098 400 to 1       400/402
(99 %)
11 diff
(97.3 %id)
AU132586   .q 1 to 820 2 to 821   tiling clone, capped   820/820
(100 %)
5 diff
(99.4 %id)
AU154093   .q 2491 to 3049 555 to 1   tiling clone,   555/560
(99 %)
13 diff
(97.7 %id)
DB060832 testis .r 1 to 570 2 to 571   tiling clone, capped   570/570
(100 %)
0 diff
(100 %id)
BI598259 brain, hypothalamus .r 48 to 755 1 to 713       713/714
(99 %)
17 diff
(97.7 %id)
AB371551   .r 49 to 807 1 to 760       760/760
(100 %)
3 diff
(99.7 %id)
TI_45210985   .r 49 to 755 89 to 800       712/801
(88 %)
17 diff
(97.9 %id)
CA391322 eye, RPE/choroid .r 69 to 550 1 to 482       482/482
(100 %)
0 diff
(100 %id)
AI539285 pooled .r 306 to 750 453 to 9       445/456
(97 %)
0 diff
(100 %id)
DB453081 testis .r 394 to 1076 1 to 682 R13K Q14A P30L L54X tiling clone,   682/689
(98 %)
7 diff
(99.0 %id)
F13469 brain, total brain .r 550 to 837 6 to 293       288/293
(98 %)
3 diff
(99.0 %id)
F05231 brain, total brain .r 550 to 844 6 to 300       295/300
(98 %)
7 diff
(97.7 %id)
R12038 whole brain .r 551 to 887 5 to 349   tiling clone, Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 345/371
(92 %)
12 diff
(96.8 %id)
R50871 whole brain .r 557 to 835 12 to 290     Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 279/306
(91 %)
12 diff
(96.1 %id)
R20472 whole brain .r 558 to 780 12 to 235     Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 224/244
(91 %)
6 diff
(97.6 %id)
T73999 whole brain .r 560 to 869 1 to 310       310/372
(83 %)
0 diff
(100 %id)
Z45220 brain, total brain .r 588 to 874 24 to 311       288/311
(92 %)
6 diff
(98.1 %id)
BF337032 brain, glioblastoma with EGFR amplification .r 1650 to 2483 12 to 841   tiling clone,   830/951
(87 %)
44 diff
(95.4 %id)
R45293 whole brain .r 1985 to 2477 520 to 12   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 509/509
(100 %)
22 diff
(95.7 %id)
CR742141   .r 1989 to 2477 502 to 15   tiling clone, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 488/488
(100 %)
2 diff
(99.6 %id)
R37102 whole brain .r 2087 to 2477 412 to 13   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 400/459
(87 %)
15 diff
(96.8 %id)
R50752 whole brain .r 2088 to 2477 418 to 12   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 407/479
(84 %)
19 diff
(96.1 %id)
DA303448 hippocampus .r 2133 to 2726 2 to 595   tiling clone, capped   594/594
(100 %)
1 diff
(99.9 %id)
F10134 brain, total brain .r 2165 to 2477 313 to 1       313/313
(100 %)
2 diff
(99.4 %id)
Z38251 brain, total brain .r 2186 to 2477 292 to 1       292/292
(100 %)
1 diff
(99.7 %id)
F04106 brain, total brain .r 2234 to 2477 244 to 1       244/244
(100 %)
1 diff
(99.6 %id)
T87208 whole brain .r 2294 to 2481 191 to 5       187/191
(97 %)
0 diff
(100 %id)
BC109217 PCR rescued clones .s 1 to 2441 1 to 2442 G38W C39L R40Q H41A K42* tiling clone,   2442/2442
(100 %)
3 diff
(99.9 %id)
DB214425 trachea .s 59 to 535 2 to 478   capped   477/477
(100 %)
0 diff
(100 %id)
DA384356 thalamus .s 88 to 718 2 to 632   tiling clone, capped   631/631
(100 %)
0 diff
(100 %id)
DB511713 testis .s 2077 to 2696 80 to 693   tiling clone, Submitted on the opposite strand 614/694
(88 %)
8 diff
(98.9 %id)
DA297944 hippocampus .t 1 to 573 2 to 574 exact tiling clone, to resequence, capped   573/573
(100 %)
0 diff
(100 %id)
DB445197.
matches multiple genes
testis .t 3 to 424 1 to 424 L10P S11V N12Q R13*   also hits gene blaslubu 424/425
(99 %)
4 diff
(99.1 %id)
DB448990 testis .t 14 to 447 1 to 434 exact     434/434
(100 %)
0 diff
(100 %id)
DB307893 hippocampus .t 1393 to 1797 406 to 1   tiling clone, to resequence,   406/408
(99 %)
1 diff
(99.8 %id)
AK311663 thymus .u 1 to 897 1 to 897   tiling clone,   897/897
(100 %)
2 diff
(99.8 %id)
DA741635   .u 2 to 511 2 to 511   tiling clone, capped   510/510
(100 %)
1 diff
(99.9 %id)
DB070195 testis .u 2 to 523 2 to 523   capped   522/522
(100 %)
2 diff
(99.7 %id)
DB147618 thymus .u 2 to 562 2 to 563   capped   562/562
(100 %)
3 diff
(99.5 %id)
CN260360 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .u 41 to 620 1 to 579       579/579
(100 %)
3 diff
(99.5 %id)
BE301292 carcinoma cell line, cervix .u 92 to 619 1 to 528     Submitted on the opposite strand 528/528
(100 %)
1 diff
(99.9 %id)
DA819904   .u 770 to 1349 2 to 581   tiling clone, capped   580/580
(100 %)
0 diff
(100 %id)
DA615121   .u 1065 to 1611 2 to 549   tiling clone, capped   548/548
(100 %)
1 diff
(99.9 %id)
DA384507 thalamus .va-u 1 to 565 2 to 567   tiling clone, capped   566/566
(100 %)
1 diff
(99.9 %id)
BF194753 fibrotheoma, ovary .va-u 321 to 853 534 to 2 exact tiling clone,   533/534
(99 %)
0 diff
(100 %id)
CF995233 Human Placenta, placenta .vb 1 to 779 28 to 817 V114G S115I V116C T117D S118F ... tiling clone,   790/818
(96 %)
22 diff
(97.4 %id)
CN288360 embryonic stem cells, cell lines H1, H7, andH9 .vc-u 1 to 726 1 to 726 A26D tiling clone,   726/726
(100 %)
1 diff
(99.9 %id)
DB446498 testis .vd 1 to 710 1 to 710 exact tiling clone,   710/710
(100 %)
18 diff
(97.5 %id)
BG724120 testis .ve-u 1 to 692 4 to 694 G6V G7E A8R T9P L10S ... tiling clone, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 694/694
(100 %)
5 diff
(99.3 %id)
AL699404 human skeletal muscle .vf-u 1 to 645 1 to 645 L48H A68T tiling clone,   645/645
(100 %)
2 diff
(99.7 %id)
BQ067593 pooled brain, lung, testis .vg 1 to 602 11 to 617 A2G A3S tiling clone,   607/1119
(54 %)
20 diff
(98.3 %id)
DA809118 brain .vh 1 to 534 2 to 535 I22M tiling clone, capped   534/534
(100 %)
3 diff
(99.5 %id)
AI125216   .vi 1 to 494 496 to 3 exact tiling clone,   494/496
(99 %)
0 diff
(100 %id)
AA326147 brain, cerebellum Gene MTRR, variant not shown              
DA179498 amygdala Gene MTRR, variant not shown       capped      
CN282833 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells Gene MTRR, variant not shown              
AL079566 testis Gene MTRR, variant not shown         This clone was ignored    
AL079567 testis Gene MTRR, variant not shown       AAA This clone was ignored    
BX501299 Liver Gene MTRR, variant not shown              
DB318850 heart Gene MTRR, variant not shown         Suspected internal deletion, this clone was ignored    
DA565352 heart Gene MTRR, variant not shown       capped Suspected internal deletion, this clone was ignored    
AA079165   Gene MTRR, variant not shown         This clone was ignored    
AA079166   Gene MTRR, variant not shown       AAA This clone was ignored    
BF126672 Liver Gene MTRR, variant not shown         Suspected internal deletion, this clone was ignored    
BF127284 Liver Gene MTRR, variant not shown         Suspected internal deletion, this clone was ignored    
BQ943117 sciatic nerve Gene MTRR, variant not shown              
CD656180 Embryonic Stem cells Gene MTRR, variant not shown              
DB100548 testis Gene MTRR, variant not shown       capped      
DB138605 thymus Gene MTRR, variant not shown       capped      
DB345206 thymus Gene MTRR, variant not shown              
DB215270 trachea Gene MTRR, variant not shown       capped      
DB349028 trachea Gene MTRR, variant not shown              
DB259563 uterus Gene MTRR, variant not shown       capped      
DB351567 uterus Gene MTRR, variant not shown              
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i-u, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va-u, .vb, .vc-u, .vd, .ve-u, .vf-u, .vg, .vh, .vi Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI